US 11510887
Sobetirome in the treatment of myelination diseases
granted A61KA61K31/192A61K9/0053
Quick answer
US patent 11510887 (Sobetirome in the treatment of myelination diseases) held by United States Government as represented by the Department of Veterans Affairs expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/192, A61K9/0053, A61K9/0095, A61P